Neurotek. Consulta y laboratorio de Disautonomía

08/01/2026

Explicacion muy clara sobre el SRAA

02/01/2026

Receptores Adrenergicos localización y funcion

Receptores adrenérgicos: base molecular de la respuesta simpática.
Receptores alfa y beta, sus subtipos, acoplamiento a la proteína G y efectos fisiológicos.
Esencial para comprender la acción farmacológica y la práctica clínica.

Comenta “PSICO” para recibir acceso a nuestra guía de Farmacología Clínica 2026.
Descarga: https://pay.kiwify.com/tS6Bs0a

01/01/2026

Un ensayo clinico en long covid entre los mas prometedores del año segun Nature

28/12/2025

Descartar un síndrome de activación mastocitaria es fundamental en pacientes con disautonomia

27/12/2025

Dysautonomia Unpacked: Understanding the Umbrella of Invisible Symptoms and Related Conditions

24/12/2025

Congratulations Michael!!!

Our deepest congratulations to our founder, Michael J. Fox as The Academy presents him with the Jean Hersholt Humanitarian Award for his tireless advocacy and boundless optimism to change the future for millions of people and families in the community.
For more information about Parkinson's disease (symptoms, diagnosis, and treatment), please visit this official website:
https://tinyurl.com/protocol01

17/12/2025

La disautonomia es un síntoma nuclear en el long covid

Researchers at University of Minnesota and Baylor University recently published a new study in the Journal of the American College of Cardiology (JACC) finding that Long COVID patients experience autonomic dysfunction similar to people with pure autonomic failure, a severe neurodegenerative type of dysautonomia typically seen in older adults. Read the abstract at: https://www.jacc.org/doi/10.1016/j.jacc.2025.09.1608

This is quite different from another article that recently published in JACC, from Harvard/Mass General and UT Southwestern researchers, which claimed there was little to no autonomic dysfunction in Long COVID patients: https://www.jacc.org/doi/abs/10.1016/j.jacc.2025.04.038

We've been monitoring research from around the world that documents the rate of autonomic dysfunction in Long COVID, and while there are some differences amongst centers, most studies are finding POTS in about 30% of Long COVID patients, and other manifestations of dysautonomia in another 40% of Long COVID patients - for a total of about 70% of Long COVID patients having some form of dysautonomia.

It's important for people with Long COVID to know if they have dysautonomia contributing to their symptoms, because there are a wide range of treatments available that can help mitigate symptoms caused by autonomic dysfunction. Dysautonomia can cause symptoms like lightheadedness, dizziness, fainting, profound fatigue, cognitive impairment, headaches, swallowing problems and other GI dysmotiity, bladder dysfunction, palpitations, chest pain, shortness of breath, an internal shaking/tremulous feeling, sleep difficulties, feeling "wired but tired," sweating abnormalities, pupil dysfunction, dry eyes/mouth/skin, and more. The autonomic nervous system also regulates immune function, coagulation, connective tissue synthesis and repair, hormones, glucose metabolism, and blood volume, amongst other systems.

We continue to meet patients who are being told "there's nothing we can do for Long COVID." If your doctor has said that to you... find a better doctor! Our regional support groups are a great place to find doctor recommendations from other local patients: dysautonomiainternational.org/support

08/12/2025

No todas las AMS tienen disautonomia

Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study https://hubs.la/Q03X6GZN0

03/12/2025

El sistema nervioso autónomo o intestinal, tiene entidad propia y participa en funciones tan importantes como el peristalmismo, las secreciones y la absorción y mantenimiento de la barrera hemato-intestinal

19/11/2025

El CISNS aprobó ayer la designación y redesignación de 37 Centros, Servicios y Unidades de Referencia del Sistema Nacional de Salud

12/11/2025

Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD)



IAPRD

Log in:

https://www.prd-journal.com/article/S1353-8020(25)00758-8/fulltext

04/09/2025

Los filamentos de cadena ligera pueden ser un buen biomarcador de daño axonal

A 𝐧𝐞𝐮𝐫𝐨𝐟𝐢𝐥𝐚𝐦𝐞𝐧𝐭 is an intermediate filament with three isoforms (light, medium, and heavy) that is expressed specifically in neurons. Neurofilaments form heteropolymers and are crucial constituents of the cytoskeleton, particularly in axons. During neuronal or axonal breakdown, neurofilaments are released extracellularly and can be measured in blood or cerebrospinal fluid as a biomarker of neurodegeneration.